Maria Gonzalez

3PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Feb 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan

|Mar 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

Irene L M Reijers, Disha Rao, Judith M Versluis

Pageof 1